Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) American Society of Hematology 2023 Investor Conference Call December 14, 2023 8:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations George Yancopoulos - Board Co-Chair, Co-Founder, President and Chief Scientific Officer Andres Sirulnik - Senior Vice President, Translational & Clinical Sciences, Hematology Conference Call Participants Beth Scott - TD Cowen Nicole Germino - Truist Securities Carter Gould - Barclays Malcolm Hoffman - BMO C ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Piper Sandler 35th Annual Healthcare Conference Call November 28, 2023 8:30 AM ET Company Participants Bob Landry - Chief Financial Officer Ryan Crowe - Vice President, Investor Relations Conference Call Participants Chris Raymond - Piper Sandler Chris Raymond Okay. I think we are going to go ahead and started. Thanks, everybody, for being here. My name is Chris Raymond. I’m one of the biotech analysts here at Piper Sandler. Welcome the 35th Annual Piper Sandler ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Jefferies London Healthcare Conference November 15, 2023 9:30 AM ET Company Participants Bob Landry - CFO Ryan Crowe - IR Conference Call Participants Akash Tewari - Jefferies Akash Tewari Good afternoon, everyone. I was just joking with the Regeneron team. There is a biotech bear market. I don't see it in London. These are packed rooms. It’s really great to see everyone. And this is -- I also think that we are going to have an XPI rally, but that's my hot take ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Truist Securities BioPharma Symposium November 8, 2023 3:20 PM ET Company Participants Dr. Len Schleifer - President and Chief Executive Officer Ryan Crowe - Investor Relations Conference Call Participants Robyn Shelton - Truist Securities Robyn Shelton Good morning, everyone. What a delight to have Dr. Len Schleifer here today. I think I've known Len since I was a baby analyst. A really bad one, but much better now. And with them, we also have Ryan Crowe from I ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) UBS Biopharma Conference Call November 9, 2023 11:00 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Brook Jennings - Vice President, Immunology Marketing Conference Call Participants Colin Bristow - UBS Colin Bristow Well, good morning, and welcome to the UBS Biopharma Conference. I am Colin Bristow, one of the biotech analysts here. It's my pleasure to have Regeneron Pharmaceuticals with us today. On behalf of the company, we have Bro ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Ryan Crowe – Vice President-Investor Relations Leonard Schleifer – President and Chief Executive Officer George Yancopoulos – President and Chief Scientific Officer Marion McCourt – Executive Vice President and Head-Commercial Bob Landry – Executive Vice President and Chief Financial Officer Conference Call Participants Evan Seigerman – BMO Capital Markets Mohit Bansal – Wells Farg ...

Re ge ne r on Cor por a t e Pr e s e nt a t ion N o v e m b e r 2 0 2 3 This non-promotional presentation contains investigational data as well as forward-looking statements; actual results may vary materially. Note regarding forward-looking statements and non-GAAP financial measures Thispresentationincludesforward-lookingstatementsthatinvolverisksanduncertaintiesrelatingtofutureeventsandthefutureperformanceofRegeneronPharmaceuticals,Inc.("Regeneron"orthe"Company"),andactualeventsorresults maydiffermaterial ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 000-19034 REGENERON PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) New York ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_28724af4cc20789ed78ef5567d89200d.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_e2a3d3571654b039c0a4f59bcf278ac1.html ...